{"id":"https://openalex.org/A5111219348","orcid":"https://orcid.org/0009-0009-3502-6175","observed_orcids":["https://orcid.org/0009-0009-3502-6175"],"display_name":"Ana Claudia Machado Marra","raw_author_names":["ANA CLAUDIA Machado Marra","Ana Claudia Machado Marra"],"full_name":"ANA CLAUDIA Machado Marra","works_count":5,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5111219348","orcid":"https://orcid.org/0009-0009-3502-6175","observed_orcids":["https://orcid.org/0009-0009-3502-6175"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210107299","ror":"https://ror.org/01nfh3016","display_name":"Hospital Erasto Gaertner","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210107299"]},"years":[2025,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I4210107299","ror":"https://ror.org/01nfh3016","display_name":"Hospital Erasto Gaertner","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210107299"]}],"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","count":3,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","count":3,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","count":3,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","count":2,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","count":2,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":3.52e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","value":3.13e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","value":2.32e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","value":1.12e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","value":9.5e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9251445531845093},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.5695000290870667},{"id":"29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","score":0.48077768087387085},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.41449999809265137},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.355112224817276}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2025,"works_count":4,"oa_works_count":3,"cited_by_count":0}],"display_name_alternatives":["ANA CLAUDIA Machado Marra","Ana Claudia Machado Marra"],"block_key":"a marra","works_api_url":"https://api.openalex.org/works?filter=author.id:A5111219348","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2024-06-04T00:00:00"}